Blanch, S., Arumí De Dios, M., SEGUI PALMER, M. A., Atienza, M., AGUIRRE, E., & Gil Gil, M. J. (2023). Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS).

Blanch, Salvador, Míriam Arumí De Dios, MIQUEL ANGEL SEGUI PALMER, Manuel Atienza, ELENA AGUIRRE, y Miguel J. Gil Gil. Observational Study of HR+/HER2− Metastatic Breast Cancer Patients Treated With Abemaciclib in Spain in the Named Patient Use Program (AbemusS). 2023.

Blanch, Salvador, et al. Observational Study of HR+/HER2− Metastatic Breast Cancer Patients Treated With Abemaciclib in Spain in the Named Patient Use Program (AbemusS). 2023.